Sudarshan Jain appointed as IGBA Chairperson for 2021

Sudarshan Jain takes charge as IGBA Chairperson for 2021
Sudarshan Jain takes charge as IGBA Chairperson for 2021
12 January 2021 | News
Jain is a well-known veteran in the pharmaceutical industry and brings with him decades of strong leadership and drug policy experience
Source: linkedin.com
IGBA, the International Generic and Biosimilar Medicines Association, representing global manufacturers of generic and biosimilar medicines, has announced that Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), is taking over the position of IGBA Chair for 2021 from Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers.
The incoming IGBA Chair Sudarshan Jain is a well-known veteran in the pharmaceutical industry and brings with him decades of strong leadership and drug policy experience.

Related Keywords

Jordan ,Jordanian ,Sudarshan Jain ,Hanan Sboul ,Indian Pharmaceutical Alliance ,International Generic ,Biosimilar Medicines Association ,Secretary General ,Jordanian Association ,Active Pharmaceutical Ingredients ,Finished Products ,Tigba ,Biosimilar ,Tapi ,ஜோர்டான் ,ஜோர்டானியன் ,சுதர்ஷன் ஜெயின் ,இந்தியன் மருந்து கூட்டணி ,சர்வதேச ஜெநெரிக் ,செயலாளர் ஜநரல் ,ஜோர்டானியன் சங்கம் ,செயலில் மருந்து பொருட்கள் ,முடிந்தது ப்ராடக்ட்ஸ் ,அபி ,